Clinical Trials Browser

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT06459180 2026-04-17

TroFuse-020

Phase 3 Recruiting

686 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07216703 2026-04-17

TroFuse-036

Phase 3 Recruiting

1,023 enrolled

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT02466971 2026-04-13

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Phase 3 Active not recruiting

450 enrolled 11 charts

Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT07418749 2026-04-06

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Phase 3 Recruiting

398 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03979014 2026-03-31

NOVEL

Phase 3 Completed

1,099 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT03256916 2026-02-24

NELCER

Phase 3 Completed

348 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04697628 2026-02-24

innovaTV 301

Phase 3 Completed

502 enrolled 18 charts 2 FDA

Gynecologic

Uterine Cervical Neoplasms

NCT04221945 2026-02-20

KEYNOTE-A18

Phase 3 Completed

1,060 enrolled 30 charts 2 FDA

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT01279135 2026-02-06

PARCER

Phase 3 Completed

300 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03635567 2026-02-04

KEYNOTE-826

Phase 3 Completed

617 enrolled 29 charts 2 FDA

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT07164534 2026-02-04

CHOC-LATE

Phase 3 Not yet recruiting

316 enrolled

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

PAROLA

TroFuse-020

TroFuse-036

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

NOVEL

NELCER

innovaTV 301

KEYNOTE-A18

PARCER

KEYNOTE-826

CHOC-LATE